rs1555498092
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_024598.4(USB1):c.266-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_024598.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USB1 | NM_024598.4 | c.266-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 6 | ENST00000219281.8 | NP_078874.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Poikiloderma with neutropenia Pathogenic:2Other:1
Variant summary: USB1 c.266-1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a canonical 3' acceptor site. At least one publication reports experimental evidence that this variant affects mRNA splicing (Clericuzio_2011). The variant was absent in 251484 control chromosomes (gnomAD). c.266-1G>A has been reported in the literature in individuals affected with Poikiloderma With Neutropenia (example: Clericuzio_2011, Rattanavalai_2012). These data indicate that the variant is likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 21271650, 21967010). ClinVar contains an entry for this variant (Variation ID: 496754). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in USB1 are known to be pathogenic (PMID: 20817924, 25044170). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 21271650). This variant has been observed in individual(s) with poikiloderma with neutropenia (PMID: 21271650, 21967010). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 496754). This variant is not present in population databases (ExAC no frequency). This sequence change affects an acceptor splice site in intron 2 of the USB1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at